Literature DB >> 26501152

Diabetic Retinopathy and Diabetic Macular Edema.

Steven R Cohen, Thomas W Gardner.   

Abstract

Diabetic retinopathy and diabetic macular edema result from chronic damage to the neurovascular structures of the retina. The pathophysiology of retinal damage remains uncertain but includes metabolic and neuroinflammatory insults. These mechanisms are addressed by intensive metabolic control of the systemic disease and by the use of ocular anti-inflammatory agents, including vascular endothelial growth factor inhibitors and corticosteroids. Improved understanding of the ocular and systemic mechanisms that underlie diabetic retinopathy will lead to improved means to diagnose and treat retinopathy and better maintain vision.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26501152      PMCID: PMC4775164          DOI: 10.1159/000438970

Source DB:  PubMed          Journal:  Dev Ophthalmol        ISSN: 0250-3751


  85 in total

1.  Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy.

Authors:  Jinzi Zhou; Shuhong Wang; Xiaobo Xia
Journal:  Curr Eye Res       Date:  2012-03-12       Impact factor: 2.424

2.  Diabetic retinopathy.

Authors:  J R WOLTER
Journal:  Am J Ophthalmol       Date:  1961-05       Impact factor: 5.258

3.  Type of diabetes mellitus associated with diabetic retinitis.

Authors:  G W DANA
Journal:  AMA Arch Ophthalmol       Date:  1953-07

4.  Quantitative analysis of diabetic macular ischemia using optical coherence tomography.

Authors:  Dawn A Sim; Pearse A Keane; Simon Fung; Michael Karampelas; Srinivas R Sadda; Marcus Fruttiger; Praveen J Patel; Adnan Tufail; Catherine A Egan
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-21       Impact factor: 4.799

Review 5.  Challenges in elucidating the genetics of diabetic retinopathy.

Authors:  Jane Z Kuo; Tien Y Wong; Jerome I Rotter
Journal:  JAMA Ophthalmol       Date:  2014-01       Impact factor: 7.389

6.  Nonmydriatic ultrawide field retinal imaging compared with dilated standard 7-field 35-mm photography and retinal specialist examination for evaluation of diabetic retinopathy.

Authors:  Paolo S Silva; Jerry D Cavallerano; Jennifer K Sun; Jason Noble; Lloyd M Aiello; Lloyd Paul Aiello
Journal:  Am J Ophthalmol       Date:  2012-05-23       Impact factor: 5.258

7.  A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.

Authors:  Ranjan Rajendram; Samantha Fraser-Bell; Andrew Kaines; Michel Michaelides; Robin D Hamilton; Simona Degli Esposti; Tunde Peto; Catherine Egan; Catey Bunce; Richard David Leslie; Philip G Hykin
Journal:  Arch Ophthalmol       Date:  2012-08

8.  Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.

Authors:  A J Barber; E Lieth; S A Khin; D A Antonetti; A G Buchanan; T W Gardner
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

9.  Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications.

Authors:  Zongzhong Tong; Zhenglin Yang; Shrena Patel; Haoyu Chen; Daniel Gibbs; Xian Yang; Vincent S Hau; Yuuki Kaminoh; Jennifer Harmon; Erik Pearson; Jeanette Buehler; Yuhong Chen; Baifeng Yu; Nicholas H Tinkham; Norman A Zabriskie; Jiexi Zeng; Ling Luo; Jennifer K Sun; Manvi Prakash; Rola N Hamam; Stephen Tonna; Ryan Constantine; Cecinio C Ronquillo; SriniVas Sadda; Robert L Avery; John M Brand; Nyall London; Alfred L Anduze; George L King; Paul S Bernstein; Scott Watkins; Lynn B Jorde; Dean Y Li; Lloyd Paul Aiello; Martin R Pollak; Kang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-05       Impact factor: 11.205

10.  The prevalence of diabetic retinopathy among adults in the United States.

Authors:  John H Kempen; Benita J O'Colmain; M Cristina Leske; Steven M Haffner; Ronald Klein; Scot E Moss; Hugh R Taylor; Richard F Hamman
Journal:  Arch Ophthalmol       Date:  2004-04
View more
  32 in total

Review 1.  Role of Tissue Renin-angiotensin System and the Chymase/angiotensin-( 1-12) Axis in the Pathogenesis of Diabetic Retinopathy.

Authors:  Mohammad Shamsul Ola; Abdullah S Alhomida; Carlos M Ferrario; Sarfaraz Ahmad
Journal:  Curr Med Chem       Date:  2017       Impact factor: 4.530

2.  The inhibitory effects of Dulaglutide on cellular senescence against high glucose in human retinal endothelial cells.

Authors:  Shen Nian; Yajing Mi; Kai Ren; Shanwei Wang; Mingkai Li; Di Yang
Journal:  Hum Cell       Date:  2022-05-18       Impact factor: 4.174

Review 3.  Pediatric Diabetic Retinopathy: Updates in Prevalence, Risk Factors, Screening, and Management.

Authors:  Tyger Lin; Rose A Gubitosi-Klug; Roomasa Channa; Risa M Wolf
Journal:  Curr Diab Rep       Date:  2021-12-13       Impact factor: 4.810

4.  The importance of vascular epithelial growth factor (VEGF) and inducible nitric oxide synthase (INOS) in rhinitis medicamentosa pathogenesis: An experimental rat model study.

Authors:  Alev Cumbul; Fuat Bulut
Journal:  Histol Histopathol       Date:  2021-11-29       Impact factor: 2.303

Review 5.  Cataract Surgery Considerations for Diabetic Patients.

Authors:  Jonathan A Go; Christina A Mamalis; Sumitra S Khandelwal
Journal:  Curr Diab Rep       Date:  2021-12-30       Impact factor: 4.810

6.  Tang Wang Ming Mu Granule Attenuates Diabetic Retinopathy in Type 2 Diabetes Rats.

Authors:  Mingxia Chen; Haibo Lv; Jiakuan Gan; Junguo Ren; Jianxun Liu
Journal:  Front Physiol       Date:  2017-12-19       Impact factor: 4.566

7.  NOX2-Induced Activation of Arginase and Diabetes-Induced Retinal Endothelial Cell Senescence.

Authors:  Modesto Rojas; Tahira Lemtalsi; Haroldo A Toque; Zhimin Xu; David Fulton; Robert William Caldwell; Ruth B Caldwell
Journal:  Antioxidants (Basel)       Date:  2017-06-15

Review 8.  Diabetic Retinopathy in the Aging Population: A Perspective of Pathogenesis and Treatment.

Authors:  Sameer P Leley; Thomas A Ciulla; Ashay D Bhatwadekar
Journal:  Clin Interv Aging       Date:  2021-07-15       Impact factor: 4.458

9.  Aflibercept for clinically significant diabetic macular edema: 12-month results in daily clinical practice.

Authors:  Rafael Campos Polo; Consuelo Rubio Sánchez; Diego Manuel García Guisado; María José Díaz Luque
Journal:  Clin Ophthalmol       Date:  2018-01-08

10.  Basis and Design of a Randomized Clinical Trial to Evaluate the Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema.

Authors:  Ma Ludivina Robles-Osorio; Renata García-Franco; Carlos D Núñez-Amaro; Ximena Mira-Lorenzo; Paulina Ramírez-Neria; Wendy Hernández; Ellery López-Star; Thomas Bertsch; Gonzalo Martínez de la Escalera; Jakob Triebel; Carmen Clapp
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-29       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.